Detalhe da pesquisa
1.
Two mosquito salivary antigens demonstrate promise as biomarkers of recent exposure to P. falciparum infected mosquito bites.
medRxiv;
2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712295
2.
Persistent and multiclonal malaria parasite dynamics despite extended artemether-lumefantrine treatment in children.
Nat Commun;
15(1): 3817, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38714692
3.
Lessons Learned from the Connecticut Response to COVID-19 in Nursing Homes during the First 2 Years of the Pandemic.
J Am Med Dir Assoc;
24(10): 1573-1578.e1, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591486
4.
Tracking antimalarial drug resistance using mosquito blood meals: a cross-sectional study.
Lancet Microbe;
4(6): e461-e469, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086737
5.
Repeat Ivermectin Mass Drug Administrations for Malaria Control II: Protocol for a Double-blind, Cluster-Randomized, Placebo-Controlled Trial for the Integrated Control of Malaria.
JMIR Res Protoc;
12: e41197, 2023 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36939832
6.
Striving towards true equity in global health: A checklist for bilateral research partnerships.
PLOS Glob Public Health;
3(1): e0001418, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36963065
7.
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi.
Malar J;
22(1): 32, 2023 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707795
8.
Moving towards malaria elimination with safer treatment for children with G6PD deficiency.
Lancet Infect Dis;
23(4): 388-390, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36462525
9.
Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda.
Clin Pharmacol Ther;
113(3): 660-669, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260349
10.
The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial.
Clin Infect Dis;
76(3): 443-452, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130191
11.
Clinical characteristics of Plasmodium falciparum infection among symptomatic patients presenting to a major urban military hospital in Cameroon.
Malar J;
21(1): 298, 2022 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36273147
12.
Genetic Variants of Glucose-6-Phosphate Dehydrogenase and Their Associated Enzyme Activity: A Systematic Review and Meta-Analysis.
Pathogens;
11(9)2022 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36145477
13.
Towards rainbow portable Cytophone with laser diodes for global disease diagnostics.
Sci Rep;
12(1): 8671, 2022 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35606373
14.
Repeatability and reproducibility of a handheld quantitative G6PD diagnostic.
PLoS Negl Trop Dis;
16(2): e0010174, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176015
15.
Repeat positive SARS-CoV-2 RNA testing in nursing home residents during the initial 9 months of the COVID-19 pandemic: an observational retrospective analysis.
Lancet Reg Health Am;
3: 100054, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34458887
16.
Mapping partner drug resistance to guide antimalarial combination therapy policies in sub-Saharan Africa.
Proc Natl Acad Sci U S A;
118(29)2021 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261791
17.
Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data.
Clin Trials;
18(5): 582-593, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34218684
18.
Four Human Cases of Eastern Equine Encephalitis in Connecticut, USA, during a Larger Regional Outbreak, 2019.
Emerg Infect Dis;
27(8)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289334
19.
SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USA.
Emerg Infect Dis;
27(5): 1288-1295, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33900171
20.
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021.
MMWR Morb Mortal Wkly Rep;
70(11): 396-401, 2021 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33735160